AlphaFold predicted structure
MCCC2 · Q9HCC0

Mean pLDDT
94.7/ 100
Very high
563 residues
Confidence breakdown
- Very high(≥ 90)93%
- Confident(70–90)3%
- Low(50–70)3%
- Very low(< 50)2%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
methylcrotonyl-CoA carboxylase subunit 2
Annotations refreshed 11 hours ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
Fetal anomalies
BIALLELIC, autosomal or pseudoautosomalHyperammonaemia
3-methylcrotonyl-CoA carboxylase 2 deficiency
Isolated 3-methylcrotonyl-CoA carboxylase deficiency
3-methylcrotonyl-CoA carboxylase deficiency
hereditary disease
autism spectrum disorder
spinal muscular atrophy, type IV
Parkinson disease
multiple sclerosis
lysosomal storage disease
Alzheimer disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial
Carboxyltransferase subunit of the 3-methylcrotonyl-CoA carboxylase, an enzyme that catalyzes the conversion of 3-methylcrotonyl-CoA to 3-methylglutaconyl-CoA, a critical step for leucine and isovaleric acid catabolism
MCCC2 · Q9HCC0

Mean pLDDT
94.7/ 100
Very high
563 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0